{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:26:59Z","timestamp":1787873219602,"version":"build-2784847793"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Azithromycin (AZM) effectively reduces asthma exacerbations and enhances bronchial epithelial cell (BEC) antiviral immunity <jats:italic>in vitro<\/jats:italic>. However, its clinical impact on different asthma phenotypes is not fully elucidated and differences in treatment response to AZM may be attributable to differences in immune activation to rhinovirus (RV) infection in different inflammatory asthma phenotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To explore bronchial epithelial antiviral properties in response to <jats:italic>in vitro<\/jats:italic> AZM treatment in eosinophilic and non-eosinophilic as well as atopic and non-atopic asthma phenotypes, and to investigate the effects of AZM on the release of RV-induced alarmins and pro-inflammatory cytokines in these asthma phenotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this cross-sectional study, we have collected BECs from patients with moderate-to-severe asthma (<jats:italic>n<\/jats:italic>\u2009=\u200920). The cells were pre-treated with or without 10\u2005\u00b5M AZM 24\u2005h before infection with 0.05 MOI RV. Release of IFN-\u03b2, IFN-\u03bb, alarmins and pro-inflammatory cytokines were measured 48\u2005h after infection by Mesoscale Discovery (S-plex and U-plex) and then compared across asthma phenotypes, based on blood eosinophils and atopy status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>AZM significantly enhanced IFN-\u03b2 and IFN-\u03bb protein release in response to RV infection both in eosinophilic and in non-eosinophilic asthma as well as in non-atopic asthma. A less pronounced IFN-\u03b2 and IFN-\u03bb protein release was also observed in the atopic group. AZM's interferon-inducing effect was, however, largely similar regardless of blood eosinophil count and atopy status. Additionally, AZM prompted the release of TSLP and IL-6 in the non-eosinophilic group only.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data suggest that <jats:italic>in vitro<\/jats:italic>, AZM works primarily by improving bronchial epithelial antiviral resistance by increasing interferons independent of eosinophilia and atopy status, highlighting the broad applicability of AZM in modulating antiviral immunity in asthma as well as the need for identifying predictors of AZM response beyond inflammatory phenotypes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2025.1605109","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:09Z","timestamp":1750138089000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of in vitro azithromycin treatment on bronchial epithelial antiviral immunity in asthma phenotypes"],"prefix":"10.3389","volume":"6","author":[{"given":"Muzhda","family":"Ghanizada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Malm Tillgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Praeger-Jahnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihaya Mahmoud","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse","family":"Ditlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Frost Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"Dyhre-Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Cerps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger","family":"Sverrild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Porsbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Uller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Lapperre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/bmj.324.7340.763","article-title":"Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study","volume":"324","author":"Green","year":"2002","journal-title":"Br Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/thx.2005.042523","article-title":"Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children","volume":"61","author":"Murray","year":"2006","journal-title":"Thorax"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00761","article-title":"More than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis","volume":"11","author":"Frey","year":"2020","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jaip.2019.11.009","article-title":"Exacerbation-prone asthma","volume":"8","author":"Denlinger","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/cea.12428","article-title":"How rhinovirus infections cause exacerbations of asthma","volume":"45","author":"Gern","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21238907","article-title":"The airway epithelium\u2014a central player in asthma pathogenesis","volume":"21","author":"Calv\u00e9n","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/mi.2012.118","article-title":"Impaired innate interferon induction in severe therapy resistant atopic asthmatic children","volume":"6","author":"Edwards","year":"2013","journal-title":"Mucosal Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/thx.2009.125930","article-title":"Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-\u03b2 in bronchial epithelial cells from donors with asthma","volume":"65","author":"Uller","year":"2010","journal-title":"Thorax"},{"key":"B11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark","year":"2005","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2102333","DOI":"10.1183\/13993003.02333-2021","article-title":"Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic","volume":"60","author":"Porsbjerg","year":"2022","journal-title":"Eur Respir J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00974","article-title":"Airway epithelial cell immunity is delayed during rhinovirus infection in asthma and COPD","volume":"11","author":"Veerati","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jaci.2012.08.005","article-title":"Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma","volume":"130","author":"Baraldo","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa044080","article-title":"The effect of telithromycin in acute exacerbations of asthma","volume":"354","author":"Johnston","year":"2006","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1399-3038.2012.01280.x","article-title":"Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study","volume":"23","author":"Koutsoubari","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"B20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/thoraxjnl-2013-204517","article-title":"The impact of azithromycin therapy on the airway microbiota in asthma","volume":"69","author":"Slater","year":"2014","journal-title":"Thorax"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-017-1022-6","article-title":"Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma","volume":"17","author":"Lopes Dos Santos Santiago","year":"2017","journal-title":"BMC Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"28698","DOI":"10.1038\/srep28698","article-title":"Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients","volume":"6","author":"Menzel","year":"2016","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31601","DOI":"10.18632\/oncotarget.16364","article-title":"Azithromycin augments rhinovirus-induced IFNbeta via cytosolic MDA5 in experimental models of asthma exacerbation","volume":"8","author":"Menzel","year":"2017","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1093\/jac\/dkw222","article-title":"Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium","volume":"71","author":"Porter","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"B25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur Respir J"},{"key":"B26","article-title":"GINA-2021-Main-Report_FINAL_21_04_28-WMS","year":"2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2013-203618","article-title":"British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults","volume":"68","author":"Du Rand","year":"2013","journal-title":"Thorax"},{"key":"B28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","article-title":"Adaptive linear step-up procedures that control the false discovery rate","volume":"93","author":"Benjamini","year":"2006","journal-title":"Biometrika"},{"key":"B29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1043661802002384","article-title":"Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000\u2005mg daily","volume":"46","author":"Di Paolo","year":"2002","journal-title":"Pharmacol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2000260","DOI":"10.1183\/13993003.00260-2020","article-title":"Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics","volume":"56","author":"Porsbjerg","year":"2020","journal-title":"Eur Respir J"},{"key":"B32","first-page":"899","article-title":"Azithromycin inhibits double-stranded RNA-induced thymic stromal lymphopoietin release from human airway epithelial cells","volume":"68","author":"Zhu","year":"2013","journal-title":"Pharmazie"},{"key":"B33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2011.05.038","article-title":"Defective epithelial barrier function in asthma","volume":"128","author":"Xiao","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1164\/rccm.200603-392OC","article-title":"Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma","volume":"174","author":"Kicic","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.18502\/ijaai.v21i2.9220","article-title":"Study effect of azithromycin and doxycycline in mucus producing and inflammatory signaling pathways of allergic asthma","volume":"21","author":"Wang","year":"2022","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.1900755","article-title":"IL-6 deficiency exacerbates allergic asthma and abrogates the protective effect of allergic inflammation against Streptococcus pneumoniae pathogenesis","volume":"205","author":"Schmit","year":"2020","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/thx.2010.136523","article-title":"Sputum IL-6 concentrations in severe asthma and its relationship with FEV1","volume":"66","author":"Morjaria","year":"2011","journal-title":"Thorax. England"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.4049\/jimmunol.0802923","article-title":"IL-6 is required for airway mucus production induced by inhaled fungal allergens1","volume":"183","author":"Neveu","year":"2009","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1128\/IAI.01169-09","article-title":"Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection","volume":"78","author":"Herbold","year":"2010","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14814\/phy2.12334","article-title":"Comprehensive evaluation of poly(I:C) induced inflammatory response in an airway epithelial model","volume":"3","author":"Lever","year":"2015","journal-title":"Physiol Rep"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1605109\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:10Z","timestamp":1750138090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1605109\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":41,"alternative-id":["10.3389\/falgy.2025.1605109"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1605109","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1605109"}}